These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 34814947)

  • 1. TLR2 and TLR4 in Parkinson's disease pathogenesis: the environment takes a toll on the gut.
    Gorecki AM; Anyaegbu CC; Anderton RS
    Transl Neurodegener; 2021 Nov; 10(1):47. PubMed ID: 34814947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Toll-like receptors influence Parkinson's disease in the microbiome-gut-brain axis.
    Zhang Z; Liu Z; Lv A; Fan C
    Front Immunol; 2023; 14():1154626. PubMed ID: 37207228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Toll-like receptors and neuroinflammation in Parkinson's disease.
    Heidari A; Yazdanpanah N; Rezaei N
    J Neuroinflammation; 2022 Jun; 19(1):135. PubMed ID: 35668422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein induces prodromal symptoms of Parkinson's disease via activating TLR2/MyD88/NF-κB pathway in Schwann cells of vagus nerve in a rat model.
    Cheng Y; Tong Q; Yuan Y; Song X; Jiang W; Wang Y; Li W; Li Y; Zhang K
    J Neuroinflammation; 2023 Feb; 20(1):36. PubMed ID: 36788559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology.
    Dzamko N; Gysbers A; Perera G; Bahar A; Shankar A; Gao J; Fu Y; Halliday GM
    Acta Neuropathol; 2017 Feb; 133(2):303-319. PubMed ID: 27888296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating the biosynthesis and TLR4-interaction of lipopolysaccharide as an approach to counter gut dysbiosis and Parkinson's disease: Role of phyto-compounds.
    Roy R; Kumar D; Bhattacharya P; Borah A
    Neurochem Int; 2024 Sep; 178():105803. PubMed ID: 38992819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
    Dogra N; Mani RJ; Katare DP
    Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 4 deficiency facilitates α-synuclein propagation and neurodegeneration in a mouse model of prodromal Parkinson's disease.
    Venezia S; Kaufmann WA; Wenning GK; Stefanova N
    Parkinsonism Relat Disord; 2021 Oct; 91():59-65. PubMed ID: 34530328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice.
    Perez-Pardo P; Dodiya HB; Engen PA; Forsyth CB; Huschens AM; Shaikh M; Voigt RM; Naqib A; Green SJ; Kordower JH; Shannon KM; Garssen J; Kraneveld AD; Keshavarzian A
    Gut; 2019 May; 68(5):829-843. PubMed ID: 30554160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients.
    Doorn KJ; Moors T; Drukarch B; van de Berg WDj; Lucassen PJ; van Dam AM
    Acta Neuropathol Commun; 2014 Aug; 2():90. PubMed ID: 25099483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut-to-Brain α-Synuclein Transmission in Parkinson's Disease: Evidence for Prion-like Mechanisms.
    Chen M; Mor DE
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration.
    Mahbub NU; Islam MM; Hong ST; Chung HJ
    Front Cell Infect Microbiol; 2024; 14():1348279. PubMed ID: 38435303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-
    Zhao Z; Li F; Ning J; Peng R; Shang J; Liu H; Shang M; Bao XQ; Zhang D
    Acta Pharm Sin B; 2021 Sep; 11(9):2859-2879. PubMed ID: 34589401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR4 and TLR2 activation is differentially associated with age during Parkinson's disease.
    Rocha Sobrinho HMD; Silva DJD; Gomides LF; Dorta ML; Oliveira MAP; Ribeiro-Dias F
    Immunol Invest; 2018 Jan; 47(1):71-88. PubMed ID: 29077524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
    Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
    Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinflammation and protein pathology in Parkinson's disease dementia.
    Kouli A; Camacho M; Allinson K; Williams-Gray CH
    Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease.
    Drouin-Ouellet J; St-Amour I; Saint-Pierre M; Lamontagne-Proulx J; Kriz J; Barker RA; Cicchetti F
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal Bacteria Maintain Adult Enteric Nervous System and Nitrergic Neurons via Toll-like Receptor 2-induced Neurogenesis in Mice.
    Yarandi SS; Kulkarni S; Saha M; Sylvia KE; Sears CL; Pasricha PJ
    Gastroenterology; 2020 Jul; 159(1):200-213.e8. PubMed ID: 32234538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.